Carotid Intima-Media Thickness in Indian Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and a Meta-Analysis

被引:0
|
作者
Kumar, Ramesh [1 ]
Narayan, Ruchika [2 ]
机构
[1] All India Inst Med Sci, Gastroenterol, Patna, India
[2] All India Inst Med Sci, Radiodiag, Patna, India
关键词
from india; atherosclerotic cardiovascular disease; carotid atherosclerosis; carotid intima-media thickness (cimt); non-alcoholic fatty liver; INSULIN-RESISTANCE; ATHEROSCLEROSIS; ASSOCIATION; OBESITY; NAFLD; RISK; NASH;
D O I
10.7759/cureus.68439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a significant association of non-alcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD). Most CVDs begin with atherosclerosis in the arteries, which can be reliably measured as the carotid intima-media thickness (CIMT) by ultrasound. Given that ethnic and regional differences have an impact on NAFLD, we aimed to evaluate the association of NAFLD patients from India with subclinical atherosclerosis, measured as CIMT. A thorough literature search was performed on four electronic databases using combinations of several keywords. The relevant data were pooled in a random or fixed-effect model, based on heterogeneity, to calculate the pooled standardised mean difference (SMD), or odds ratio (OR) with 95% confidence interval (CI). The final analysis included a total of 15 studies with 1196 NAFLD and 1482 control subjects. NAFLD patients had a 21.3% higher mean CIMT than the controls. The pooled SMD was 1.001 (95% CI: 0.627-1.375, p < 0.001). Three studies that balanced cardiometabolic risk factors found a similar association (p = 0.037). Furthermore, NAFLD was significantly associated with the presence of high (>0.8 mm) CIMT (pooled OR = 5.4, 95% CI: 2.0-14 .9) and carotid plaques (pooled OR = 10.24, 95% CI: 5.74-18.26). The mean CIMT was also higher in diabetic NAFLD than in the diabetic control (pooled SMD = 1.07, 95% CI = 0.818-1.324, p < 0.001). There is a significant positive association between the marker of subclinical atherosclerosis and NAFLD in India. This might give more light on screening and follow-up plans for such patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis
    Candia, R.
    Ruiz, A.
    Torres-Robles, R.
    Chavez-Tapia, N.
    Mendez-Sanchez, N.
    Arrese, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (04) : 656 - 662
  • [32] Effects of curcumin in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Malik, Adnan
    Malik, Muhammad
    CANADIAN LIVER JOURNAL, 2024, 7 (02): : 299 - 315
  • [33] Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis
    Elgebaly, Ahmed
    Radwan, Ibrahim A. I.
    AboElnas, Mohamed M.
    Ibrahim, Hamza H.
    Eltoomy, Moutaz F. M.
    Atta, Ahmed A.
    Mesalam, Hend A.
    Sayed, Alaa A.
    Othman, Amr A.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2017, 26 (01) : 59 - 67
  • [34] Non-alcoholic fatty liver disease is associated with carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance
    Cho, Y. -W.
    Choi, Y. -J.
    Park, S. -W.
    Lee, E. -J.
    Huh, K. -B.
    DIABETOLOGIA, 2012, 55 : S503 - S504
  • [35] The Prevalence and Association Between Non-Alcoholic Fatty Pancreas Disease and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Randich, Karla Hernandez
    Chaponan-Lavalle, Andres
    Norwood, Dalton A.
    Montalvan-Sanchez, Eleazar E.
    Izquierdo-Veraza, Diego
    Riva-Moscoso, Adrian
    Sevilla-Acosta, Eduardo
    Calderon, Eduardo
    Ramirez-Rojas, Mirian
    Calderon, Gerardo
    Beas, Renato
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S49 - S50
  • [36] Statins' efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Boutari, Chrysoula
    Pappas, Panagiotis D.
    Anastasilakis, Dimitrios
    Mantzoros, Christos S.
    CLINICAL NUTRITION, 2022, 41 (10) : 2195 - 2206
  • [37] Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Wang, Hu
    Wang, Li
    Cheng, Yujia
    Xia, Zhiqing
    Liao, Yifeng
    Cao, Jiang
    BIOMEDICAL REPORTS, 2018, 9 (01) : 90 - 96
  • [38] Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
    Polyzos, Stergios A.
    Aronis, Konstantinos N.
    Kountouras, Jannis
    Raptis, Dimitrios D.
    Vasiloglou, Maria F.
    Mantzoros, Christos S.
    DIABETOLOGIA, 2016, 59 (01) : 30 - 43
  • [39] Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
    Stergios A. Polyzos
    Konstantinos N. Aronis
    Jannis Kountouras
    Dimitrios D. Raptis
    Maria F. Vasiloglou
    Christos S. Mantzoros
    Diabetologia, 2016, 59 : 30 - 43
  • [40] Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis
    Tabaeian, Seidamir P.
    Rezapour, Aziz
    Azari, Samad
    Martini, Mariano
    Saran, Maryam
    Behzadifar, Meysam
    Shahabi, Saeed
    Sayyad, Abdollah
    Tahernejad, Ali
    Bragazzi, N. L.
    Ehsanzadeh, S. J.
    Behzadifar, Masoud
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (01)